Amivas Ireland Ltd - search results

European Union - English - EMA (European Medicines Agency)

artesunate amivas

amivas ireland ltd - artesunate - malaria - antiprotozoals - artesunate amivas is indicated for the initial treatment of severe malaria in adults and children.consideration should be given to official guidance on the appropriate use of antimalarial agents.

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

ramivasc 2.5 capsules, hard 2.5 mg

salama pharmaceuticals limited, tanzania - ramipril - capsules, hard - 2.5 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

amivas tablet

amico laboratories ltd. - rosuvastatin - tablet - 5 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

amivas 10 tablet

amico laboratories ltd. - rosuvastatin - tablet - 10 mg

United States - English - NLM (National Library of Medicine)

artesunate kit

amivas, inc - artesunate (unii: 60w3249t9m) (.alpha.-dihydroartemisinin - unii:x0uiv26abx) - artesunate for injection is indicated for the initial treatment of severe malaria in adult and pediatric patients. treatment of severe malaria with artesunate for injection should always be followed by a complete treatment course of an appropriate oral antimalarial regimen [see dosage and administration (2.1)] . limitations of use artesunate for injection does not treat the hypnozoite liver stage forms of plasmodium and will therefore not prevent relapses of malaria due to plasmodium vivax or plasmodium ovale . concomitant therapy with an antimalarial agent such as an 8-aminoquinoline drug is necessary for the treatment of severe malaria due to p. vivax or p. ovale [see dosage and administration (2.1)] . known serious hypersensitivity to artesunate, such as anaphylaxis [see warnings and precautions (5.2) and adverse reactions (6.2)] . there are serious risks to the mother and fetus associated with untreated severe malaria during pregnancy; delaying treatment of severe malaria in pregnancy may result in ser